Skip to main content

Table 1 Patient and treatment characteristics

From: The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer

No. Sex Age Site Stage RT Chemotherapy Local response Site of failure TTP (months) Survival (months)
      Dose (Gy/Fxs) CCRT After CCRT     
1 M 42 Head T4N1 50/20 5-FU GEM SD Distant 7.6 12.1*
2 M 64 Head T4N0 50/20 5-FU GEM PR    7.6*
3 M 72 RM Recurrent 50/20 5-FU GEM SD Distant 7.9 26.0*
4 F 61 Head T4N0 50/20 5-FU GEM PR    7.2*
5 M 74 Body T4N0 50/20 5-FU GEM SD Distant 2.0 9.8*
6 M 63 Tail T4N0 50/20 5-FU GEM PR Distant 6.0 9.2*
7 F 61 Celiac trunk Recurrent 50/20 5-FU 5-FU/LV PR Distant 8.0 12.8*
8 M 66 Body T4N1 50/20 5-FU   SD Local/Distant 14.6 22.7*
9 M 71 Body T4N0 50/20 5-FU GEM PR Distant 13.9 19.4*
10 M 68 Head T4N0 45/15 5-FU GEM PR Distant 8.0 20.0*
11 F 56 Celiac trunk Recurrent 45/15 5-FU GEM PR Distant 4.9 6.9
12 F 66 Head T4N1 45/15 5-FU GEM SD    5.7
  1. Abbreviations: RT = radiotherapy; CCRT = concurrent chemoradiation; GEM = gemcitabine; 5-FU = 5-fluorouracil; LV = leucovorin; TTP = time to progression; PR = partial regression; SD = stable disease; RM = resection margin.
  2. * Dead.
  3. Recurrent disease after curative resection.